Comparing Anzu Special Acquisition Corp I (NASDAQ:ANZUW) & Vyome (NASDAQ:HIND)

Vyome (NASDAQ:HIND) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.

Insider & Institutional Ownership

22.1% of Vyome shares are held by institutional investors. 33.0% of Vyome shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Vyome and Anzu Special Acquisition Corp I’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vyome	-69.71%	-216.95%	-69.42%
Anzu Special Acquisition Corp I	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Vyome and Anzu Special Acquisition Corp I, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	0	0	2	0	3.00
Anzu Special Acquisition Corp I	0	0	0	0	0.00

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 147.93%. Given Vyome’s stronger consensus rating and higher probable upside, equities analysts clearly believe Vyome is more favorable than Anzu Special Acquisition Corp I.

Valuation and Earnings

This table compares Vyome and Anzu Special Acquisition Corp I”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$8.01 million	2.76	-$7.13 million	($433.08)	-0.01
Anzu Special Acquisition Corp I	N/A	N/A	N/A	N/A	N/A

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Vyome.

Summary

Vyome beats Anzu Special Acquisition Corp I on 6 of the 9 factors compared between the two stocks.

About Vyome

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

About Anzu Special Acquisition Corp I

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.